Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global (ABILITY)
ABILITY Diabetes Global
Sponsor: Concept Medical Inc.
This NA trial investigates Acute Coronary Syndrome and Coronary Artery Disease and is currently ongoing. Concept Medical Inc. leads this study, which shows 14 recorded versions since 2020 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
14 versions recorded-
Dec 2025 — Present [monthly]
Unknown NA
-
Sep 2025 — Dec 2025 [monthly]
Unknown NA
-
Apr 2025 — Sep 2025 [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Apr 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
▶ Show 9 earlier versions
-
Apr 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Nov 2022 — Apr 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2022 — Nov 2022 [monthly]
Recruiting NA
-
Apr 2022 — Sep 2022 [monthly]
Recruiting NA
-
Jan 2021 — Apr 2022 [monthly]
Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
-
Aug 2020 — Nov 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2020 — Aug 2020 [monthly]
Not Yet Recruiting NA
-
Feb 2020 — May 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Concept Medical Inc.
For direct contact, visit the study record on ClinicalTrials.gov .